← Patent-cliff monitor small molecule FANAPT ILOPERIDONE
Loss of exclusivity December 2031 latest FDA-listed patent expiry
Drug detail Brand name FANAPT Active ingredient ILOPERIDONE Strength 6MG Dosage form TABLET Route ORAL Modality Small molecule FDA approval May 2009 Marketing status RX
Listed patents Patent Expires Type 9074254 December 2031 use U-1674 9074256 February 2031 use U-1674 9072742 January 2031 use U-1674 9074255 December 2030 use U-1674 8999638 October 2030 use U-1674 12606869 September 2030 use U-4505 8652776 August 2030 use U-1685 9157121 April 2030 use U-1674 8586610 November 2027 use U-1625
Regulatory exclusivity Code Expires I-939 April 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.